Transient suppression of equine immune responses by equine infectious anemia virus (EIAV)
- PMID: 1651604
- DOI: 10.1016/0042-6822(91)90821-r
Transient suppression of equine immune responses by equine infectious anemia virus (EIAV)
Abstract
Suppression of the immune system is a common aspect of the disease pathogenesis associated with retroviral infections in both man and animals. We have measured transient suppression of the equine immune system as a loss or decrease in antigen-specific and polyclonal lymphocyte proliferation following experimental infection of ponies with three variants of equine infectious anemia virus (EIAV) with difference virulence characteristics. The transient suppression of proliferative responses was temporally associated with recurrent febrile episodes, which are the hallmark symptom of EIAV-induced disease. Decreased proliferative responses occurred at all times when EIAV viremia was identified, based on the detection of an infectious virus in plasma or viral proteins on peripheral blood mononuclear cells. The immunosuppression was observed most frequently in ponies infected with virulent variants of EIAV which suggested that this effect may contribute to disease pathogenesis. Suppression of polyclonal proliferative responses was induced in vitro by the addition of either infectious or heat-inactivated EIAV to cultures, demonstrating that the viral structural proteins were immunosuppressive in the absence of infection. These studies indicated that EIAV is similar to other retroviruses in that it has the ability to suppress the immune system.
Similar articles
-
Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge.Clin Diagn Lab Immunol. 2005 Aug;12(8):983-93. doi: 10.1128/CDLI.12.8.983-993.2005. Clin Diagn Lab Immunol. 2005. PMID: 16085917 Free PMC article.
-
Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus.J Virol. 1992 Jun;66(6):3398-408. doi: 10.1128/JVI.66.6.3398-3408.1992. J Virol. 1992. PMID: 1316455 Free PMC article. Clinical Trial.
-
Cytotoxic T lymphocytes in protection against equine infectious anemia virus.Anim Health Res Rev. 2004 Dec;5(2):271-6. doi: 10.1079/ahr200482. Anim Health Res Rev. 2004. PMID: 15984338 Review.
-
Immunopathogenesis of equine infectious anemia lentivirus disease.Dev Biol Stand. 1990;72:31-7. Dev Biol Stand. 1990. PMID: 2178127 Review.
-
Detection and induction of equine infectious anemia virus-specific cytotoxic T-lymphocyte responses by use of recombinant retroviral vectors.J Virol. 1999 Apr;73(4):2762-9. doi: 10.1128/JVI.73.4.2762-2769.1999. J Virol. 1999. PMID: 10074123 Free PMC article.
Cited by
-
Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process.J Virol. 1997 May;71(5):3840-52. doi: 10.1128/JVI.71.5.3840-3852.1997. J Virol. 1997. PMID: 9094660 Free PMC article.
-
Epitope specificity is critical for high and moderate avidity cytotoxic T lymphocytes associated with control of viral load and clinical disease in horses with equine infectious anemia virus.Virology. 2003 Sep 1;313(2):537-52. doi: 10.1016/s0042-6822(03)00344-1. Virology. 2003. PMID: 12954220 Free PMC article.
-
Lymphocyte proliferation responses induced to broadly reactive Th peptides did not protect against equine infectious anemia virus challenge.Clin Diagn Lab Immunol. 2005 Aug;12(8):983-93. doi: 10.1128/CDLI.12.8.983-993.2005. Clin Diagn Lab Immunol. 2005. PMID: 16085917 Free PMC article.
-
The immunopathogenesis of equine infectious anemia virus.Virus Res. 1994 May;32(2):111-38. doi: 10.1016/0168-1702(94)90038-8. Virus Res. 1994. PMID: 8067050 Free PMC article. Review. No abstract available.
-
Early detection of dominant Env-specific and subdominant Gag-specific CD8+ lymphocytes in equine infectious anemia virus-infected horses using major histocompatibility complex class I/peptide tetrameric complexes.Virology. 2005 Aug 15;339(1):110-26. doi: 10.1016/j.virol.2005.05.025. Virology. 2005. PMID: 15979679 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources